Go Deep
Sunrest Lifescience Limited
Sunrest Lifescience Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,218 | 7.7 | 1.56 | 0.86 | 61.65 |
| Oct 2026 | 20,363 | 7.7 | 1.56 | 0.85 | 61.65 |
Sunrest Lifescience Limited Quarterly Results
Quarterly data isn't available for this company right now.
Sunrest Lifescience Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 708,278,000.0 | 333,937,000.0 | 294,716,000.0 | 240,438,000.0 | — |
| Net Profit | 41,163,000.0 | 20,053,000.0 | 2,257,000.0 | 20,431,000.0 | — |
| EPS | — | 3.6 | 0.6 | 4.0 | 1.5 |
Sunrest Lifescience Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 714,141,000.0 | 586,496,000.0 | 251,555,000.0 | 167,120,000.0 | — |
| Total Liabilities | 417,901,000.0 | 370,201,000.0 | 109,701,000.0 | 135,984,000.0 | — |
| Total Equity | 204,273,000.0 | 163,109,000.0 | 141,854,000.0 | 31,136,000.0 | — |
Owes vs Owns
Sunrest Lifescience Limited owed ₹0.59 for every ₹1 it owned in Mar 2026, down from ₹0.81 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.59× | 0.63× | 0.44× | 0.81× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Sunrest Lifescience Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 3.9%Receivables 45.5%Inventory 23.9%Fixed assets (tangible) 11.9%Other assets 14.8%
How it's funded — Mar 2026
Short-term debt 7.7%Long-term debt 16.7%Payables 29.4%Other liabilities 4.6%Shareholders' equity 41.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2.8 | 1.7 | 0.3 | 0.4 |
| Receivables | 32.5 | 36.4 | 15.0 | 10.9 |
| Inventory | 17.1 | 9.6 | 5.1 | 3.9 |
| Fixed assets (tangible) | 8.5 | 4.4 | 0.3 | 0.4 |
| Intangible assets | 0.1 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 10.5 | 6.5 | 4.5 | 1.1 |
| Liabilities & equity | ||||
| Short-term debt | 5.5 | 6.3 | 2.7 | 0.1 |
| Long-term debt | 12.0 | 5.7 | 3.5 | 2.0 |
| Payables | 21.0 | 22.9 | 3.8 | 8.6 |
| Other liabilities | 3.3 | 2.0 | 1.0 | 2.8 |
| Shareholders' equity | 29.6 | 21.6 | 14.2 | 3.1 |
| Net tangible assets | 20.3 | 16.3 | 14.2 | 3.1 |
Sunrest Lifescience Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -500,000.0 | 29,208,000.0 | -147,975,000.0 | 11,548,000.0 | — |
| Investing Activities | -29,135,000.0 | -11,450,000.0 | -71,000.0 | -307,000.0 | — |
| Financing Activities | 39,898,000.0 | -3,272,000.0 | 146,443,000.0 | -11,542,000.0 | — |